Cargando…
Multidrug‐resistant transporter expression does not always result in drug resistance
Autores principales: | Le Large, Tessa Ya Sung, El Hassouni, Btissame, Kazemier, Geert, Piersma, Sander R., van Laarhoven, Hanneke W. M., Bijlsma, Maarten F., Jimenez, Cornelia R., Giovannetti, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172061/ https://www.ncbi.nlm.nih.gov/pubmed/30195264 http://dx.doi.org/10.1111/cas.13756 |
Ejemplares similares
-
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatment
por: Le Large, Tessa Ya Sung, et al.
Publicado: (2019) -
Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020) -
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
por: Le Large, T. Y. S., et al.
Publicado: (2021) -
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
por: Boyd, Lenka N.C., et al.
Publicado: (2022) -
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
por: Mantini, G., et al.
Publicado: (2020)